Other Local Peers |
BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), REPLIGEN CORP (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), UNIQURE N.V. (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), NATERA INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), XENCOR INC (NASDAQ), INSMED INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), CHEMOCENTRYX INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), REGENXBIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), NEXTCURE INC (NASDAQ), ALECTOR INC (NASDAQ), VERACYTE INC (NASDAQ), VIELA BIO INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), INTREXON CORP (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), OMEROS CORP (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), AVROBIO INC (NASDAQ), DERMIRA INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), KURA ONCOLOGY INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CYTOKINETICS INC (NASDAQ), RETROPHIN INC (NASDAQ), ARDELYX INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), IMMUNOGEN INC (NASDAQ), AGENUS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), MACROGENICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MERUS B V (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), AVID BIOSERVICES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), BELLUS HEALTH INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), RECRO PHARMA INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), COMPUGEN (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PERSONALIS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), KAMADA (NASDAQ), SERES THERAPEUTICS (NASDAQ), IVERIC BIO INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), NANTKWEST INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), CHIASMA INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), ATHERSYS INC (NASDAQ), ARAVIVE INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), IMV INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), CHIMERIX INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), VERASTEM INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), INFLARX N V (NASDAQ), ADURO BIOTECH INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), EQUILLIUM INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SYNLOGIC INC (NASDAQ), OTONOMY INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), COHBAR INC (NASDAQ), VERMILLION INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), TREVENA INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), SAVARA INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), INMUNE BIO INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ZAFGEN INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOCARDIA INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), SOLIGENIX INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), ADVAXIS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SENESTECH INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), VAXART INC (NASDAQ), PRECIPIO INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), TOCAGEN INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), OCUGEN INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), BIOCEPT INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), TROVAGENE INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), OPGEN INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), SPHERIX INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ) |
Other Global Peers |
HAOHAI BIOTEC (HKEx), ALPHAMAB ONCOLOGY (HKEx), MYOVANT SCIENCES LTD (NYSE), FRONTAGE (HKEx), CKLIFE SCIENCES (HKEx), POLYNOVO LIMITED (ASX), VIVA BIOTECH (HKEx), AVITA MEDICAL LTD (ASX), ASCENTAGE-B (HKEx), KADMON HLDGS INC (NYSE), MESOBLAST LTD (ASX), SINOMAB BIO-B (HKEx), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), ARCUS BIOSCIENCES INC (NYSE), STARPHARMA HOLDINGS LIMITED (ASX), LEE'S PHARM (HKEx), PFENEX INC (NYSE American), TELIX PHARMACEUTIC (ASX), DPHARMA (Bursa), NEXT SCIENCE LTD (ASX), NEUREN PHARMACEUTICALS LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), BBI LIFE SCI (HKEx), NANOVIRICIDES INC (NYSE American), UNI-BIO GROUP (HKEx), ENZO BIOCHEM INC (NYSE), PALATIN TECHNOLOGIES INC (NYSE American), RESAPP HEALTH LIMITED (ASX), PYC THERAPEUTICS LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), IMUGENE LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), CEL-SCI CORP (NYSE American), ONCOSIL MEDICAL LIMITED (ASX), IMMUTEP LTD (ASX), ORTHOCELL LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CT ENTERPRISE (HKEx), PORT (SET), ARMATA PHARMACEUTICALS INC (NYSE American), ISORAY INC (NYSE American), BIOSINO BIO-TEC (HKEx), BIONOMICS LTD (ASX), INVEX THERAPEUTICS LTD NPV (ASX), KAZIA THERAPEUTICS LIMITED (ASX), NOVITA HEALTHCARE LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), REGENT PACIFIC (HKEx), BIOTRON (ASX), ORAGENICS INC (NYSE American), MEMPHASYS LTD (ASX), RHINOMED LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), EXTRAWELL PHAR (HKEx), IBIO INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), PROTEOMICS INTL LABORATORIES LTD (ASX), IMMURON LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), CELLMID LIMITED (ASX), REGENEUS LTD (ASX), PATRYS LIMITED (ASX), ANTEOTECH LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), Suntar Eco-City^ (SGX), HOLISTA COLLTECH LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), ADALTA LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CCP TECHNOLOGIES LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), AUSTRALIAN PRIMARY HEMP LTD (ASX), BENITEC BIOPHARMA LTD (ASX), MEGASUN (Bursa), HAO WEN HLDGS (HKEx), MGRC (Bursa), SIENNA CANCER DIAGNOSTICS LTD (ASX), MEDIBIO LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), TBG DIAGNOSTICS LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), BIOXYNE LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AIM IMMUNOTECH INC (NYSE American), QT Vascular (SGX), BPH ENERGY LIMITED (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX) |